Vensana Capital, based in Minnesota, backs healthtech and life sciences companies at Series A and B, can lead rounds with $10M to $30M checks, and its latest fund is $425M.
8 people on the investing team, 6 of them partners who can make the call. Partners are listed first.








Work here and something is wrong? Ask for a correction.


Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckOne email when this firm shows new activity. Nothing else.
Vensana Capital reports entry at series a, series b.
Vensana Capital reports checks of $10M to $30M+.
Yes. Vensana Capital says it can lead.
Justin Klein (Co-founder and Managing Partner), Kirk Nielsen (Co-founder and Managing Partner), Amrinder Singh (Partner), Greg Banker (Partner), Maria Berkman (Partner), Mike Kramer (Partner).
No recent activity since September 2026.
Work at Vensana Capital? Claim or correct this profile.